Budesonide
Showing 1 - 25 of 695
Microscopic Colitis Trial (Budesonide MMX®, Budesonide controlled ileal release (CR) capsules)
Not yet recruiting
- Microscopic Colitis
- Budesonide MMX®
- Budesonide controlled ileal release (CR) capsules
- (no location specified)
Jun 13, 2023
Chronic Rhinosinusitis With Nasal Polyps Trial in Kafrelsheikh (Budesonide, Prednisone, Saline)
Completed
- Chronic Rhinosinusitis With Nasal Polyps
- Budesonide
- +2 more
-
Kafrelsheikh, EgyptKafrelsheikh University hospital
Jul 3, 2023
Ulcerative Colitis Trial (High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching rectal foam)
Not yet recruiting
- Ulcerative Colitis
- High dose budesonide rectal foam
- +2 more
- (no location specified)
Jul 28, 2023
Asthma in Children Trial in Shaoxing (pharmacist-led patient-centered medication therapy management)
Recruiting
- Asthma in Children
- pharmacist-led patient-centered medication therapy management
-
Shaoxing, Zhejiang, ChinaShaoxing Maternity and Child Care hospital
Oct 7, 2023
Epigenetic Effects of Intranasal Steroids, Environmental Exposure Trial in Vancouver (Budesonide Nasal, Placebo)
Active, not recruiting
- Epigenetic Effects of Intranasal Steroids
- Environmental Exposure
- Budesonide Nasal
- Placebo
-
Vancouver, British Columbia, CanadaUniversity of British Columbia
Nov 10, 2022
Asthma Trial in Erpent (AQ001S 0.125 mg/ml, Budesonide 0.125 mg/ml inhalation suspension)
Recruiting
- Asthma
- AQ001S 0.125 mg/ml
- Budesonide 0.125 mg/ml inhalation suspension
-
Erpent, Namur, BelgiumPneumocare SPRL
Nov 2, 2022
Engraftment Syndrome Trial (Budesonide)
Not yet recruiting
- Engraftment Syndrome
- Budesonide
- (no location specified)
Aug 19, 2022
Infant, Extremely Premature, Acute Lung Injury, Chronic Lung Disease of Prematurity Trial in Tucson (Infants in the study group
Recruiting
- Infant, Extremely Premature
- +3 more
- Infants in the study group (S/B group) will receive surfactant 2.5 mls/kg and Budesonide 0.5 mg (1mL)
- Infants in the control group (S/P group) receive placebo (Normal saline 1mL)
-
Tucson, ArizonaUniversity of Arizona
Oct 31, 2022
COPD Trial in Glendale (Treatment A: BGF MDI HFO, Treatment B: BGF MDI HFA)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A: BGF MDI HFO
- Treatment B: BGF MDI HFA
-
Glendale, CaliforniaResearch Site
Jan 18, 2023
Heathy Participants Trial (Treatment A (BDA MDI HFO), Treatment B (BDA MDI HFA))
Not yet recruiting
- Heathy Participants
- Treatment A (BDA MDI HFO)
- Treatment B (BDA MDI HFA)
- (no location specified)
Nov 15, 2023
Multiple Myeloma Trial in Salt Lake City (Budesonide EC, Placebo)
Not yet recruiting
- Multiple Myeloma
- Budesonide EC
- Placebo
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Jan 9, 2023
CRS, Polyp, Nasal Trial in Kafrelsheikh (Budesonide intrapolyp injection, Budesonide nasal wash, Prednisolone tablets)
Recruiting
- CRS
- Polyp, Nasal
- Budesonide intrapolyp injection
- +2 more
-
Kafrelsheikh, EgyptKafrelsheikh University hospital
Jul 24, 2022
Eosinophilic Esophagitis Trial in Rozzano (Budesonide Orodispersible Tablets (Jorveza))
Not yet recruiting
- Eosinophilic Esophagitis
- Budesonide Orodispersible Tablets (Jorveza)
-
Rozzano, Milano, ItalyDepartment of Gastroenterology, Humanitas Research Hospital
Oct 21, 2022
Snoring, Mouth Breathing Trial in Changsha (Nebulized Budesonide, Intranasal Budesonide Spray)
Not yet recruiting
- Snoring
- Mouth Breathing
- Nebulized Budesonide
- Intranasal Budesonide Spray
-
Changsha, Hunan, ChinaDepartment of Otolaryngology, Second Xiangya Hospital, Central S
Apr 16, 2022
Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis Trial in Sherbrooke (Budesonide 0.5 MG/ML, Mometasone nasal spray)
Terminated
- Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis
- Budesonide 0.5 MG/ML
- Mometasone nasal spray
-
Sherbrooke, Quebec, CanadaUniversité de Sherbrooke
Sep 16, 2022
Ulcerative Colitis Trial (Low Dose Budesonide, High Dose Budesonide, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Low Dose Budesonide
- +2 more
- (no location specified)
Sep 7, 2022
Chronic Rhinosinusitis (Diagnosis) Trial in Londrina (Budesonide Nasal, Placebos)
Recruiting
- Chronic Rhinosinusitis (Diagnosis)
- Budesonide Nasal
- Placebos
-
Londrina, Paraná, BrazilMarco Aurelio Fornazieri
Sep 12, 2022
Asthma Trial in Rotterdam (Budesonide/Formoterol fumarate dihydrate)
Recruiting
- Asthma
- Budesonide/Formoterol fumarate dihydrate
-
Rotterdam, Zuid-Holland, NetherlandsFranciscus Gasthuis & Vlietland
Apr 14, 2023
Chronic Rhinosinusitis (Diagnosis) Trial (Budesonide, Mucosal Atomization Device, NeilMed squeeze bottle for Impregnated Nasal
Withdrawn
- Chronic Rhinosinusitis (Diagnosis)
- Budesonide
- +2 more
- (no location specified)
Jul 7, 2022
Ulcerative Colitis Chronic Trial (Budesonide MMX, Prednisolone)
Not yet recruiting
- Ulcerative Colitis Chronic
- Budesonide MMX
- Prednisolone
- (no location specified)
Apr 17, 2022
Quality of Life With Administration of Fixed Combination of
Completed
- Asthma
- Quality of Life
- Budesonide/Formoterol treated patients
-
Athens, Mesogion Ave. 152, Greece7th Pulmonary Dept, Athens Chest Hospital
Sep 7, 2022
COPD Trial in Brooklyn (Treatment A (BGF MDI HFO with oral activated charcoal), Treatment B (BGF MDI HFA with oral activated
Recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A (BGF MDI HFO with oral activated charcoal)
- Treatment B (BGF MDI HFA with oral activated charcoal)
-
Brooklyn, MarylandResearch Site
Aug 11, 2022
Eosinophilic Esophagitis Trial (Budesonide Gel)
Not yet recruiting
- Eosinophilic Esophagitis
- Budesonide Gel
- (no location specified)
May 23, 2022
Moderate Asthma Trial in São Paulo (Administration of investigation drug, Administration of comparator)
Not yet recruiting
- Moderate Asthma
- Administration of investigation drug
- Administration of comparator
-
São Paulo, BrazilEurofarma Laboratorios S.A
Feb 9, 2023